Survival of HIV-1 in syringes: Effects of temperature during storage

被引:26
作者
Abdala, N
Reyes, R
Carney, JM
Heimer, R
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[2] Amherst Coll, Amherst, MA 01002 USA
关键词
injection drug use; syringes; HIV-1; transmission; culture;
D O I
10.3109/10826080009148220
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In a previous paper we demonstrated that HIV-1 survival in syringes was strongly associated with the volume of blood remaining and with the duration of storage at room temperature. The current study was performed to determine the effects of storage temperature upon the survival of HIV-1 inside syringes. At 4 degrees C, 50% of all syringes contained viable HIV-1 at 42 days of storage, the longest storage duration tested. At room temperature (20 degrees C), the last day that syringes with 2 mu L of infected blood were positive was Day 21, and viable HIV-1 was recovered from 8% of syringes. The last day on which syringes with 20 mu L were positive was Day 42, and viable HIV-1 was recovered from 8% of syringes. Above room temperature (27, 32, and 37 degrees C), the likelihood of encountering syringes with viable HIV-1 when periods of storage exceeded 1 week decreased to less than 1%. The temperatures at which drug injectors are likely to store their used syringes will vary according to climate, season, and circumstances faced by the injector. The. survival of HIV-1 in contaminated syringes varied over a range of temperatures, and this may be a factor influencing the syringe-borne transmission of HIV-1.
引用
收藏
页码:1369 / 1383
页数:15
相关论文
共 26 条
[1]   Survival of HIV-1 in syringes [J].
Abdala, N ;
Stephens, PC ;
Griffith, BP ;
Heimer, R .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01) :73-80
[2]  
[Anonymous], 1973, RIPPING RUNNING
[3]   The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments [J].
Bourgois, P .
SUBSTANCE USE & MISUSE, 1998, 33 (11) :2323-2351
[4]  
*CDCP, 1998, SURV REP, V10
[5]   HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN HETEROSEXUAL INTRAVENOUS-DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
MOSS, AR ;
ONISHI, R ;
OSMOND, D ;
CARLSON, JR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (02) :169-172
[6]   COCAINE USE AND HIV INFECTION IN INTRAVENOUS DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
BACCHETTI, P ;
OSMOND, D ;
BRODIE, B ;
SANDE, MA ;
MOSS, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (04) :561-565
[7]   RISK-FACTORS FOR HIV-1 SEROCONVERSION AMONG INJECTION-DRUG USERS - A CASE-CONTROL STUDY [J].
CHITWOOD, DD ;
GRIFFIN, DK ;
COMERFORD, M ;
PAGE, JB ;
TRAPIDO, EJ ;
LAI, SG ;
MCCOY, CB .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (11) :1538-1542
[8]  
Clatts MC, 1999, J ACQ IMMUN DEF SYND, V22, P194
[9]   RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG OUT-OF-TREATMENT DRUG INJECTORS IN HIGH AND LOW SEROPREVALENCE CITIES [J].
FRIEDMAN, SR ;
JOSE, B ;
DEREN, S ;
JARLAIS, DCD ;
NEAIGUS, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (08) :864-874
[10]   BLOODY NEEDLES - THE VOLUMES OF BLOOD TRANSFERRED IN SIMULATIONS OF NEEDLESTICK INJURIES AND SHARED USE OF SYRINGES FOR INJECTION OF INTRAVENOUS DRUGS [J].
GAUGHWIN, MD ;
GOWANS, E ;
ALI, R ;
BURRELL, C .
AIDS, 1991, 5 (08) :1025-1027